Onions could hold key to fighting antibiotic resistance

January 22, 2018, University College London
Credit: University College London

A type of onion could help the fight against antibiotic resistance in cases of tuberculosis, a UCL and Birkbeck-led study suggests.

Researchers believe the antibacterial properties extracted from the Persian shallot could increase the effects of existing .

The study, published in Scientific Reports, was led by Dr. Sanjib Bhakta of Birkbeck, University of London and UCL's Professor Simon Gibbons, who worked with a team of scientists from Birkbeck, UCL, the University of Greenwich, the University of East London and Royal Free Hospital.

When a patient has a bacterial infection, they may be prescribed an antibiotic. In the case of TB, they will likely be prescribed a cocktail of four including Isoniazid and Rifampicin – but increasingly, the pathogens in bacterial infections are developing to antibiotic drugs.

This means the loses its ability to effectively control or kill harmful bacteria, and is free to grow and cause further damage to the patient which, can be passed along to the population at large. Therefore, there is a pressing need to develop new classes of antibacterials to combat , which this research may help progress.

The team investigated extracts of bulbs from Allium Stipitatum – also known as the Persian shallot and used as a staple part of Iranian cooking – and its antibacterial effects. They synthesised the chemical compounds present in these plants in order to better understand and optimise their antibacterial potential.

They tested four different synthesised compounds, all of which showed a significant reduction in the presence of the bacteria in the multidrug-resistant tuberculosis – the most promising candidate of which, with highest therapeutic index, inhibited growth of the isolated TB cells by more than 99.9%.

The team concluded that the chemical compounds may work as templates for the discovery of new drug treatment to combat strains of tuberculosis, which have previously developed resistance to anti-bacterial drugs.

Dr. Bhakta, of Birkbeck's Department of Biological Sciences, said: "Despite a concerted global effort to prevent the spread of tuberculosis, approximately 10 million new cases and two million deaths were reported in 2016. As many as 50 million people worldwide are currently infected with multi-drug resistant TB, which means it's vital to develop new antibacterials.

"In searching for new antibacterials, we tend to focus on molecules that are potent enough to be developed commercially as new drug entities by themselves. However, in this study we show that by inhibiting the key intrinsic resistance properties of the TB, one could increase the effects of existing antibiotic treatment and reverse the tide of already existing drug resistance."

Professor Gibbons, Head of UCL Pharmaceutical and Biological Chemistry, said: "Natural products from plants and microbes have enormous potential as a source of new antibiotics. Nature is an amazingly creative chemist and it is likely that plants such as the Persian shallot produce these chemicals as a defence against microbes in their environment. Dr. Bhakta and I will be dedicating our research to discovering new antibiotics and understanding how they function. We believe that nature holds the key for new antibiotic chemotypes."

Explore further: Supercharged antibiotics could turn tide against superbugs

More information: Cynthia A. Danquah et al. Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition, Scientific Reports (2018). DOI: 10.1038/s41598-017-18948-w

Related Stories

Supercharged antibiotics could turn tide against superbugs

January 5, 2018
An old drug supercharged by University of Queensland researchers has emerged as a new antibiotic that could destroy some of the world's most dangerous superbugs.

Bacteria from cystic fibrosis patient could help fight antibiotic-resistant TB

June 23, 2017
A newly discovered antibiotic, produced by bacteria from a cystic fibrosis patient, could be used to treat cases of drug-resistant tuberculosis (TB). This is the finding of a team of scientists from Cardiff University's School ...

New tuberculosis drugs possible with understanding of old antibiotic

December 5, 2017
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.

Bacteria from cystic fibrosis patient could help thwart antibiotic-resistant TB

June 14, 2017
The number of drug-resistant tuberculosis (TB) cases is rising globally. But a newly discovered natural antibiotic—produced by bacteria from the lung infection in a cystic fibrosis patient—could help fight these infections. ...

Drug-resistant infections are a 'global health emergency': WHO

September 20, 2017
Resistance to antibiotic drugs is a "global health emergency" that threatens the progress made by modern medicine, the head of the UN's health agency warned as a new report was published Wednesday.

Recommended for you

Kidney docs worry over no dialysis for undocumented immigrants

May 21, 2018
(HealthDay)—Undocumented immigrants in the United States are often denied treatment for kidney failure until they have a life-threatening emergency. Now a new study finds that the doctors and nurses who treat them are frustrated ...

Helping preterm infants grow bigger kidneys would prevent kidney disease later in life

May 21, 2018
Nephrons are the microscopic blood-filtering units inside our kidneys that convert waste products into urine, regulate our electrolyte levels and our blood pressure.

Clues found to early lung transplant failure

May 21, 2018
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages ...

How to ethically conduct clinical research during public health emergencies

May 21, 2018
Following the 2014-2015 Ebola outbreak in West Africa, the U.S. National Academy of Sciences, Engineering and Medicine established a committee to assess the clinical trials conducted in Guinea, Sierra Leone and Liberia. In ...

Anxious women may want to keep an eye on their bone health

May 18, 2018
(HealthDay)—As if older women didn't already worry enough about their bone health, new research suggests that anxiety may up their risk for fractures.

New strategy to cure chronic hepatitis B infection

May 18, 2018
Scientists from Karolinska Institutet and Hannover Medical School have published two studies that provide insights into how the immune system responds and helps to clear a hepatitis B infection after treatment interruption. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.